AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 65 filers reported holding AVADEL PHARMACEUTICALS PLC in Q3 2018. The put-call ratio across all filers is 1.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $120,000 | -84.4% | 15,165 | -85.2% | 0.00% | -100.0% |
Q4 2019 | $771,000 | +970.8% | 102,171 | +771.5% | 0.00% | – |
Q2 2018 | $72,000 | -65.7% | 11,724 | -41.4% | 0.00% | -100.0% |
Q3 2017 | $210,000 | +16.0% | 20,000 | +22.0% | 0.00% | 0.0% |
Q2 2017 | $181,000 | – | 16,400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 1,625,000 | $12,269,000 | 3.04% |
GENDELL JEFFREY L | 1,146,764 | $8,658,000 | 1.11% |
Broadfin Capital, LLC | 1,029,012 | $7,769,000 | 1.04% |
RTW INVESTMENTS, LP | 3,401,434 | $25,681,000 | 0.97% |
BRANDES INVESTMENT PARTNERS, LP | 3,651,948 | $27,571,000 | 0.66% |
Aristides Capital LLC | 71,520 | $540,000 | 0.42% |
Tekla Capital Management LLC | 814,588 | $6,150,000 | 0.23% |
INVESTORS ASSET MANAGEMENT OF GEORGIA INC /GA/ /ADV | 36,100 | $273,000 | 0.17% |
Leap Investments LP | 43,481 | $328,000 | 0.15% |
Brown Capital Management | 1,829,886 | $13,816,000 | 0.13% |